Related Experiment Video
Updated: May 10, 2026
Ultrasensitive Detection of Biomarkers by Using a Molecular Imprinting Based Capacitive Biosensor
Published on: February 16, 2018
Immuno-PCR: A high-sensitivity approach for biomarker analysis.
Hansen Shi1, Biyun Zeng2, Qiping Wei3
1Laboratory Medicine Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, China; Key Laboratory of Antibody Engineering of Guangdong Higher Education Institutes, School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, Guangdong, China.
Immuno-Polymerase Chain Reaction (iPCR) offers highly sensitive and specific detection of disease biomarkers. This innovative technique aids in early diagnosis, monitoring, and prognosis across various conditions, improving patient outcomes.
Area of Science:
- Biotechnology
- Immunology
- Molecular Biology
Background:
- Immuno-Polymerase Chain Reaction (iPCR) integrates immunology and molecular biology for biomarker detection.
- iPCR excels in identifying low-concentration or unstable pathophysiologic biomarkers.
- The technology offers superior sensitivity and specificity for disease diagnosis.
Purpose of the Study:
- To review the current applications of iPCR in detecting various disease biomarkers.
- To introduce the principle, advantages, limitations, and clinical significance of iPCR.
- To promote the widespread application of iPCR in disease diagnosis.
Main Methods:
- Review of existing literature on Immuno-Polymerase Chain Reaction (iPCR).
- Analysis of iPCR applications in cancer, infection, autoimmune, cardiovascular, and neurological diseases.
- Discussion of iPCR principles, advantages, limitations, and clinical significance.
Main Results:
- iPCR has demonstrated value in early disease diagnosis, monitoring, and prognosis.
- Applications span detection of biomarkers for cancer, infection, autoimmune, cardiovascular, and neurological diseases.
- The technology facilitates early detection and intervention, enhancing patient outcomes.
Conclusions:
- iPCR is a promising, cutting-edge detection strategy for low-concentration or unstable biomarkers.
- Widespread application of iPCR in disease diagnosis can improve patient outcomes and survival rates.
- This review serves as a valuable reference for future iPCR research and clinical applications.
